Recent Posts by DMI

rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes

rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes This patent enables rHEALTH’s unique technology to measure many analytes in a given small volume sample at home or in the clinic CAMBRIDGE, Mass., January 23, 2019 /PRWeb/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that...
Read more

rHEALTH Technology to be Presented at NASA’s 2019 HRP IWS Meeting

Dr. Chan will present the rHEALTH technology at NASA's Human Research Program (HRP) Investigator's Workshop (IWS). The rHEALTH blood sensor is the subject of a NASA CCRPP contract to deliver comprehensive blood analysis capabilities for long-duration space travel. It is utilized in conjunction with the SKYE Sensor which enables comprehensive bioanalytical vitals information...
Read more

rHEALTH Technology Receives Notice of Allowance for New U.S. Patent Covering Small Volume Sample Consumable and Loader

CAMBRIDGE, Mass., Oct. 4, 2018 /PRNewswire-iReach/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/645,388, entitled “Sample Consumable and Loader” filed by its affiliate company, DNA Medicine Institute (DMI). This...
Read more

rHEALTH Technology Awarded in NASA’s Civilian Commercialization Readiness Pilot Program (CCRPP)

CAMBRIDGE, Mass., Aug. 20, 2018 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, a digital health solutions company, today announced that the rHEALTH technology is a subject of NASA’s Civilian Commercial Readiness Pilot Program (CCRPP). Recipients of CCRPP awards must not only demonstrate maturation of technology that aligns with NASA interests, but also...
Read more

Recent Comments by DMI

    No comments by DMI yet.